Browsing Archive: October, 2013

OptionELITE Retrievable Vena Cava Filter

Posted by Natasha Russell on Saturday, October 26, 2013,

Continuing our commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism (PE), Argon Medical Devices, Inc. takes another step forward with the launch of the Option™ELITE Retrievable Vena Cava Filter.  The OptionELITE IVC Filter, designed by Rex Medical, LP, provides the clinician with the same safe and trusted design now enhanced for ease of delivery and retrievability.

“Safety and retrievability are without question two of the most vital, and r...

Continue reading ...


Posted by Natasha Russell on Saturday, October 26, 2013,

St. Jude Medical recently announced the acquisition of Nanostim, Inc., the company that developed the world's first commercially available leadless pacemaker. The device recently received CE Mark approval and is now available in select European markets. This acquisition is the culmination of our long-standing partnership with Nanostim, as a strategic investor and collaborator in its product development and commercialization efforts.

The Nanostim™ leadless pacemaker is changing the future of ...

Continue reading ...

MitraClip (Abbott) has received Food and Drug Administration approval for patients with significant symptomatic degenerative mitral regurgitation who are at prohibitive risk for mitral valve surgery.

Posted by Natasha Russell on Saturday, October 26, 2013,

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

Treatment with Minimally Invasive Device Can Improve Quality of Life for Patients with Debilitating Mitral Valve Disease Who Are at Prohibitive Surgical Risk

October 25, 2013

Abbott Park, Ill (NYSE: ABT) — Abbott today announced that its first-in-class, catheter-based MitraClip® therapy has received U.S. Food and Drug Administration (FDA) approval and will launch immediately in the...

Continue reading ...

Managing Director, CARDIOVMEDS

I have been working in the field of Cardiology and open heart surgery since 1991. I worked first as a perfusionist, then as a cardiovascular technologist. My duties have included working in the cardiac cathetherisation lab, analysising the 24-48 hour ambulatory ECG ( holter), assisting with various diagnostic tests. I have also worked as administrator of the paediatric cardiac surgery program. Key achievements have been presentation at the Caribbean Cardiac Conference on topics such as: Diagnosing Right Ventricular Infarction : The role of the technician Familial Atrial Fibrillation (FAF) Revealed